HEADER TRANSFERASE 22-JUL-02 1M7N TITLE CRYSTAL STRUCTURE OF UNACTIVATED APO INSULIN-LIKE GROWTH FACTOR-1 TITLE 2 RECEPTOR KINASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR I RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (RESIDUES 974-1286); COMPND 5 SYNONYM: CD221 ANTIGEN; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.MUNSHI,L.KUO REVDAT 4 14-FEB-24 1M7N 1 SEQADV REVDAT 3 24-FEB-09 1M7N 1 VERSN REVDAT 2 14-JAN-03 1M7N 1 JRNL REVDAT 1 07-JAN-03 1M7N 0 JRNL AUTH S.MUNSHI,M.KORNIENKO,D.L.HALL,J.C.REID,L.WAXMAN, JRNL AUTH 2 S.M.STIRDIVANT,P.L.DARKE,L.C.KUO JRNL TITL CRYSTAL STRUCTURE OF THE APO, UNACTIVATED INSULIN-LIKE JRNL TITL 2 GROWTH FACTOR-1 RECEPTOR KINASE. IMPLICATION FOR INHIBITOR JRNL TITL 3 SPECIFICITY. JRNL REF J.BIOL.CHEM. V. 277 38797 2002 JRNL REFN ISSN 0021-9258 JRNL PMID 12138114 JRNL DOI 10.1074/JBC.M205580200 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 16172 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4768 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 219 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1M7N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUL-02. REMARK 100 THE DEPOSITION ID IS D_1000016697. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17255 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, 0.2M MGCL2, 29% PEG REMARK 280 8000, 2% ETHYLENE GLYCOL, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.03000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 970 REMARK 465 ALA A 971 REMARK 465 SER A 972 REMARK 465 VAL A 973 REMARK 465 ASN A 974 REMARK 465 PRO A 975 REMARK 465 GLU A 976 REMARK 465 TYR A 977 REMARK 465 PHE A 978 REMARK 465 GLU A 1094 REMARK 465 MET A 1095 REMARK 465 GLU A 1096 REMARK 465 ASN A 1097 REMARK 465 ASN A 1098 REMARK 465 PRO A 1099 REMARK 465 LEU A 1284 REMARK 465 PRO A 1285 REMARK 465 GLU A 1286 REMARK 465 PRO A 1287 REMARK 465 GLU A 1288 REMARK 465 GLU A 1289 REMARK 465 LEU A 1290 REMARK 465 ASP A 1291 REMARK 465 MET B 970 REMARK 465 ALA B 971 REMARK 465 SER B 972 REMARK 465 VAL B 973 REMARK 465 ASN B 974 REMARK 465 PRO B 975 REMARK 465 GLU B 976 REMARK 465 TYR B 977 REMARK 465 PHE B 978 REMARK 465 GLU B 1094 REMARK 465 MET B 1095 REMARK 465 GLU B 1096 REMARK 465 ASN B 1097 REMARK 465 ASN B 1098 REMARK 465 PRO B 1099 REMARK 465 LEU B 1284 REMARK 465 PRO B 1285 REMARK 465 GLU B 1286 REMARK 465 PRO B 1287 REMARK 465 GLU B 1288 REMARK 465 GLU B 1289 REMARK 465 LEU B 1290 REMARK 465 ASP B 1291 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 987 -153.56 -112.62 REMARK 500 ASP A1021 7.87 56.77 REMARK 500 PRO A1023 -73.85 -62.37 REMARK 500 ASN A1033 155.28 -43.56 REMARK 500 ASN A1055 67.06 -156.88 REMARK 500 VAL A1060 116.84 -36.35 REMARK 500 ARG A1131 -16.63 69.80 REMARK 500 ASP A1132 42.79 -146.44 REMARK 500 ASP A1161 2.55 -66.32 REMARK 500 LYS A1168 -140.24 -95.98 REMARK 500 ALA A1206 62.81 66.19 REMARK 500 TRP A1246 34.07 -97.29 REMARK 500 GLU A1281 -36.11 -30.55 REMARK 500 ASP B 987 -153.13 -108.41 REMARK 500 ASP B1021 -34.64 76.86 REMARK 500 ASN B1033 150.56 -44.78 REMARK 500 ASN B1055 67.37 -175.44 REMARK 500 LYS B1127 46.75 72.10 REMARK 500 ARG B1131 -13.05 66.40 REMARK 500 ASP B1132 36.99 -147.20 REMARK 500 LYS B1168 -107.66 -105.48 REMARK 500 ARG B1174 6.96 -67.03 REMARK 500 ASN B1233 82.83 54.50 REMARK 500 PRO B1235 145.53 -36.08 REMARK 500 REMARK 500 REMARK: NULL DBREF 1M7N A 971 1291 UNP P08069 IGF1R_HUMAN 974 1294 DBREF 1M7N B 971 1291 UNP P08069 IGF1R_HUMAN 974 1294 SEQADV 1M7N MET A 970 UNP P08069 CLONING ARTIFACT SEQADV 1M7N MET B 970 UNP P08069 CLONING ARTIFACT SEQRES 1 A 322 MET ALA SER VAL ASN PRO GLU TYR PHE SER ALA ALA ASP SEQRES 2 A 322 VAL TYR VAL PRO ASP GLU TRP GLU VAL ALA ARG GLU LYS SEQRES 3 A 322 ILE THR MET SER ARG GLU LEU GLY GLN GLY SER PHE GLY SEQRES 4 A 322 MET VAL TYR GLU GLY VAL ALA LYS GLY VAL VAL LYS ASP SEQRES 5 A 322 GLU PRO GLU THR ARG VAL ALA ILE LYS THR VAL ASN GLU SEQRES 6 A 322 ALA ALA SER MET ARG GLU ARG ILE GLU PHE LEU ASN GLU SEQRES 7 A 322 ALA SER VAL MET LYS GLU PHE ASN CYS HIS HIS VAL VAL SEQRES 8 A 322 ARG LEU LEU GLY VAL VAL SER GLN GLY GLN PRO THR LEU SEQRES 9 A 322 VAL ILE MET GLU LEU MET THR ARG GLY ASP LEU LYS SER SEQRES 10 A 322 TYR LEU ARG SER LEU ARG PRO GLU MET GLU ASN ASN PRO SEQRES 11 A 322 VAL LEU ALA PRO PRO SER LEU SER LYS MET ILE GLN MET SEQRES 12 A 322 ALA GLY GLU ILE ALA ASP GLY MET ALA TYR LEU ASN ALA SEQRES 13 A 322 ASN LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 A 322 MET VAL ALA GLU ASP PHE THR VAL LYS ILE GLY ASP PHE SEQRES 15 A 322 GLY MET THR ARG ASP ILE TYR GLU THR ASP TYR TYR ARG SEQRES 16 A 322 LYS GLY GLY LYS GLY LEU LEU PRO VAL ARG TRP MET SER SEQRES 17 A 322 PRO GLU SER LEU LYS ASP GLY VAL PHE THR THR TYR SER SEQRES 18 A 322 ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE ALA SEQRES 19 A 322 THR LEU ALA GLU GLN PRO TYR GLN GLY LEU SER ASN GLU SEQRES 20 A 322 GLN VAL LEU ARG PHE VAL MET GLU GLY GLY LEU LEU ASP SEQRES 21 A 322 LYS PRO ASP ASN CYS PRO ASP MET LEU PHE GLU LEU MET SEQRES 22 A 322 ARG MET CYS TRP GLN TYR ASN PRO LYS MET ARG PRO SER SEQRES 23 A 322 PHE LEU GLU ILE ILE SER SER ILE LYS GLU GLU MET GLU SEQRES 24 A 322 PRO GLY PHE ARG GLU VAL SER PHE TYR TYR SER GLU GLU SEQRES 25 A 322 ASN LYS LEU PRO GLU PRO GLU GLU LEU ASP SEQRES 1 B 322 MET ALA SER VAL ASN PRO GLU TYR PHE SER ALA ALA ASP SEQRES 2 B 322 VAL TYR VAL PRO ASP GLU TRP GLU VAL ALA ARG GLU LYS SEQRES 3 B 322 ILE THR MET SER ARG GLU LEU GLY GLN GLY SER PHE GLY SEQRES 4 B 322 MET VAL TYR GLU GLY VAL ALA LYS GLY VAL VAL LYS ASP SEQRES 5 B 322 GLU PRO GLU THR ARG VAL ALA ILE LYS THR VAL ASN GLU SEQRES 6 B 322 ALA ALA SER MET ARG GLU ARG ILE GLU PHE LEU ASN GLU SEQRES 7 B 322 ALA SER VAL MET LYS GLU PHE ASN CYS HIS HIS VAL VAL SEQRES 8 B 322 ARG LEU LEU GLY VAL VAL SER GLN GLY GLN PRO THR LEU SEQRES 9 B 322 VAL ILE MET GLU LEU MET THR ARG GLY ASP LEU LYS SER SEQRES 10 B 322 TYR LEU ARG SER LEU ARG PRO GLU MET GLU ASN ASN PRO SEQRES 11 B 322 VAL LEU ALA PRO PRO SER LEU SER LYS MET ILE GLN MET SEQRES 12 B 322 ALA GLY GLU ILE ALA ASP GLY MET ALA TYR LEU ASN ALA SEQRES 13 B 322 ASN LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 B 322 MET VAL ALA GLU ASP PHE THR VAL LYS ILE GLY ASP PHE SEQRES 15 B 322 GLY MET THR ARG ASP ILE TYR GLU THR ASP TYR TYR ARG SEQRES 16 B 322 LYS GLY GLY LYS GLY LEU LEU PRO VAL ARG TRP MET SER SEQRES 17 B 322 PRO GLU SER LEU LYS ASP GLY VAL PHE THR THR TYR SER SEQRES 18 B 322 ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE ALA SEQRES 19 B 322 THR LEU ALA GLU GLN PRO TYR GLN GLY LEU SER ASN GLU SEQRES 20 B 322 GLN VAL LEU ARG PHE VAL MET GLU GLY GLY LEU LEU ASP SEQRES 21 B 322 LYS PRO ASP ASN CYS PRO ASP MET LEU PHE GLU LEU MET SEQRES 22 B 322 ARG MET CYS TRP GLN TYR ASN PRO LYS MET ARG PRO SER SEQRES 23 B 322 PHE LEU GLU ILE ILE SER SER ILE LYS GLU GLU MET GLU SEQRES 24 B 322 PRO GLY PHE ARG GLU VAL SER PHE TYR TYR SER GLU GLU SEQRES 25 B 322 ASN LYS LEU PRO GLU PRO GLU GLU LEU ASP FORMUL 3 HOH *219(H2 O) HELIX 1 1 ALA A 992 GLU A 994 5 3 HELIX 2 2 SER A 1037 MET A 1051 1 15 HELIX 3 3 ASP A 1083 SER A 1090 1 8 HELIX 4 4 SER A 1105 ASN A 1126 1 22 HELIX 5 5 ALA A 1134 ARG A 1136 5 3 HELIX 6 6 ARG A 1155 TYR A 1162 5 8 HELIX 7 7 GLY A 1166 LYS A 1168 5 3 HELIX 8 8 PRO A 1172 MET A 1176 5 5 HELIX 9 9 SER A 1177 GLY A 1184 1 8 HELIX 10 10 THR A 1187 THR A 1204 1 18 HELIX 11 11 SER A 1214 GLU A 1224 1 11 HELIX 12 12 PRO A 1235 TRP A 1246 1 12 HELIX 13 13 ASN A 1249 ARG A 1253 5 5 HELIX 14 14 SER A 1255 ILE A 1263 1 9 HELIX 15 15 GLU A 1268 SER A 1275 1 8 HELIX 16 16 ALA B 992 GLU B 994 5 3 HELIX 17 17 SER B 1037 MET B 1051 1 15 HELIX 18 18 LYS B 1052 PHE B 1054 5 3 HELIX 19 19 ASP B 1083 SER B 1090 1 8 HELIX 20 20 SER B 1105 ASN B 1126 1 22 HELIX 21 21 ALA B 1134 ARG B 1136 5 3 HELIX 22 22 ARG B 1155 TYR B 1162 5 8 HELIX 23 23 PRO B 1172 MET B 1176 5 5 HELIX 24 24 SER B 1177 GLY B 1184 1 8 HELIX 25 25 THR B 1187 THR B 1204 1 18 HELIX 26 26 SER B 1214 GLU B 1224 1 11 HELIX 27 27 PRO B 1235 TRP B 1246 1 12 HELIX 28 28 ASN B 1249 ARG B 1253 5 5 HELIX 29 29 SER B 1255 SER B 1262 1 8 HELIX 30 30 GLY B 1270 SER B 1275 1 6 SHEET 1 A 5 ILE A 996 GLN A1004 0 SHEET 2 A 5 MET A1009 ALA A1015 -1 O VAL A1014 N THR A 997 SHEET 3 A 5 ARG A1026 THR A1031 -1 O ILE A1029 N TYR A1011 SHEET 4 A 5 LEU A1073 GLU A1077 -1 O MET A1076 N ALA A1028 SHEET 5 A 5 LEU A1062 VAL A1066 -1 N GLY A1064 O ILE A1075 SHEET 1 B 2 CYS A1138 VAL A1140 0 SHEET 2 B 2 VAL A1146 ILE A1148 -1 O LYS A1147 N MET A1139 SHEET 1 C 2 TYR A1163 ARG A1164 0 SHEET 2 C 2 LEU A1170 LEU A1171 -1 O LEU A1171 N TYR A1163 SHEET 1 D 5 ILE B 996 GLN B1004 0 SHEET 2 D 5 MET B1009 LYS B1016 -1 O VAL B1014 N THR B 997 SHEET 3 D 5 GLU B1024 THR B1031 -1 O ILE B1029 N TYR B1011 SHEET 4 D 5 LEU B1073 GLU B1077 -1 O MET B1076 N ALA B1028 SHEET 5 D 5 LEU B1062 VAL B1066 -1 N VAL B1066 O LEU B1073 SHEET 1 E 2 CYS B1138 VAL B1140 0 SHEET 2 E 2 VAL B1146 ILE B1148 -1 O LYS B1147 N MET B1139 SHEET 1 F 2 TYR B1163 ARG B1164 0 SHEET 2 F 2 LEU B1170 LEU B1171 -1 O LEU B1171 N TYR B1163 CISPEP 1 GLN A 1070 PRO A 1071 0 0.02 CISPEP 2 GLN B 1070 PRO B 1071 0 -0.13 CRYST1 52.880 78.060 78.970 90.00 99.17 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018911 0.000000 0.003053 0.00000 SCALE2 0.000000 0.012811 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012827 0.00000